Prevalence of Metabolic Syndrome and Related Characteristics in Obese Adolescents with and without Polycystic Ovary Syndrome

Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and rela...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 93; no. 12; pp. 4780 - 4786
Main Authors Rossi, Brooke, Sukalich, Sara, Droz, Jennifer, Griffin, Adam, Cook, Stephen, Blumkin, Aaron, Guzick, David S., Hoeger, Kathleen M.
Format Journal Article
LanguageEnglish
Published Bethesda, MD Oxford University Press 01.12.2008
Endocrine Society
The Endocrine Society
Subjects
Online AccessGet full text
ISSN0021-972X
1945-7197
DOI10.1210/jc.2008-1198

Cover

Abstract Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls. Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women.
AbstractList Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls. Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women.
Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls. Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women.
Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls. Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women. Obese adolescent women have a high prevalence of metabolic syndrome irrespective of polycystic ovary syndrome status, which is associated with the amount of visceral adiposity.
Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group.CONTEXTAdults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group.The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS.OBJECTIVEThe aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS.We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls.DESIGNWe conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls.A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study.PATIENTS AND PARTICIPANTSA total of 74 subjects, 43 with PCOS and 31 controls, participated in the study.Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents.INTERVENTIONSEach subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents.We measured the prevalence of MBS and its components in adolescent subjects and controls.MAIN OUTCOME MEASURESWe measured the prevalence of MBS and its components in adolescent subjects and controls.The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS.RESULTSThe PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS.Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women.CONCLUSIONSObese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women.
Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. We measured the prevalence of MBS and its components in adolescent subjects and controls. The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women.
Author Sukalich, Sara
Guzick, David S.
Griffin, Adam
Droz, Jennifer
Blumkin, Aaron
Hoeger, Kathleen M.
Cook, Stephen
Rossi, Brooke
Author_xml – sequence: 1
  givenname: Brooke
  surname: Rossi
  fullname: Rossi, Brooke
  organization: 3Department of Obstetrics and Gynecology (B.R., A.G.), Brigham and Women’s Hospital, Boston, Massachusetts 02115
– sequence: 2
  givenname: Sara
  surname: Sukalich
  fullname: Sukalich, Sara
  organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642
– sequence: 3
  givenname: Jennifer
  surname: Droz
  fullname: Droz, Jennifer
  organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642
– sequence: 4
  givenname: Adam
  surname: Griffin
  fullname: Griffin, Adam
  organization: 3Department of Obstetrics and Gynecology (B.R., A.G.), Brigham and Women’s Hospital, Boston, Massachusetts 02115
– sequence: 5
  givenname: Stephen
  surname: Cook
  fullname: Cook, Stephen
  organization: 2Pediatrics (S.C., A.B.), University of Rochester Medical Center, Rochester, New York 14642
– sequence: 6
  givenname: Aaron
  surname: Blumkin
  fullname: Blumkin, Aaron
  organization: 2Pediatrics (S.C., A.B.), University of Rochester Medical Center, Rochester, New York 14642
– sequence: 7
  givenname: David S.
  surname: Guzick
  fullname: Guzick, David S.
  organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642
– sequence: 8
  givenname: Kathleen M.
  surname: Hoeger
  fullname: Hoeger, Kathleen M.
  email: Kathy_hoeger@urmc.rochester.edu
  organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20971840$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18812482$$D View this record in MEDLINE/PubMed
BookMark eNp1ktuLEzEYxYOsuN3VN58lIOqLsyaZzCUvwlK8wUoXL-BbyGS-sSlpUpNMpeAfb2Zbqy7sUwL5ncM55JyhE-cdIPSYkgvKKHm10heMkLagVLT30IwKXhUNFc0JmhHCaCEa9u0UncW4IoRyXpUP0CltW8p4y2bo13WArbLgNGA_4I-QVOet0fjzzvXBrwEr1-NPYFWCHs-XKiidIJiYjI7YOLzoIAK-7L2FqMGliH-atLxRTRc_Jnzt7U7vJgVebFXYHb0fovuDshEeHc5z9PXtmy_z98XV4t2H-eVVoXnJU8EHqJumJwKgIX1Fu0EIVRNeA2MdK3mpYVAl07TSFWu7roESBs0oVR2rWT-U5-j13nczdmvop5hBWbkJZp3jSK-M_P_FmaX87rcyy2vOWTZ4fjAI_scIMcm1yW2tVQ78GGUt2obyqs3g01vgyo_B5XKypNmKZFJk6sm_eY5B_nxLBp4dABW1skNQTpt45BgRDW05ydzLPaeDjzHA8NeKyGkdcqXltA45rSPj7BauTVLJ-Km1sXeJXuxFftzcZX8zvvI33RHLVw
CODEN JCEMAZ
CitedBy_id crossref_primary_10_1007_s11892_014_0564_3
crossref_primary_10_1016_j_jpag_2014_05_005
crossref_primary_10_1111_j_1365_2265_2009_03604_x
crossref_primary_10_1155_2016_1473612
crossref_primary_10_1186_1472_6823_14_76
crossref_primary_10_1097_MED_0b013e32832afd4d
crossref_primary_10_1016_j_jpag_2010_06_003
crossref_primary_10_1016_j_amepre_2024_10_009
crossref_primary_10_1080_01443615_2017_1318840
crossref_primary_10_3803_EnM_2018_33_4_447
crossref_primary_10_1016_j_dsx_2019_01_002
crossref_primary_10_1016_j_jpag_2018_03_001
crossref_primary_10_1016_j_fertnstert_2014_05_032
crossref_primary_10_1159_000471804
crossref_primary_10_1016_j_jpag_2012_07_006
crossref_primary_10_3109_09513590_2011_613968
crossref_primary_10_1186_1477_7827_8_142
crossref_primary_10_1111_j_1471_0528_2009_02386_x
crossref_primary_10_1016_j_dsx_2018_03_014
crossref_primary_10_1111_j_1399_5448_2009_00559_x
crossref_primary_10_20945_2359_3997000000497
crossref_primary_10_1016_j_ejogrb_2020_04_024
crossref_primary_10_1016_j_fertnstert_2013_04_001
crossref_primary_10_1542_peds_2015_1430
crossref_primary_10_4103_jnsm_jnsm_140_20
crossref_primary_10_1007_s11154_009_9115_7
crossref_primary_10_3109_09513590903015528
crossref_primary_10_1556_OH_2013_29669
crossref_primary_10_1016_j_jpag_2014_08_011
crossref_primary_10_1590_S0004_27302009000200014
crossref_primary_10_1016_j_jadohealth_2017_09_005
crossref_primary_10_1097_GCO_0b013e32832e07d5
crossref_primary_10_1177_1358863X16682107
crossref_primary_10_1016_j_bpobgyn_2009_09_005
crossref_primary_10_1016_j_jpeds_2012_11_019
crossref_primary_10_1111_j_1447_0756_2010_01516_x
crossref_primary_10_1210_jendso_bvab060
crossref_primary_10_1177_0897190010384632
crossref_primary_10_1097_MED_0b013e32835a1a03
crossref_primary_10_1530_EJE_09_1102
crossref_primary_10_15406_emij_2018_06_00158
crossref_primary_10_1097_MED_0b013e32832c937e
crossref_primary_10_1111_cob_12123
crossref_primary_10_1155_2012_434830
crossref_primary_10_36106_ijsr_1814624
crossref_primary_10_1159_000375530
crossref_primary_10_1016_j_ogc_2008_12_004
crossref_primary_10_1210_er_2015_1104
crossref_primary_10_1016_j_fertnstert_2013_12_046
crossref_primary_10_1111_cen_13477
crossref_primary_10_1016_j_fertnstert_2010_03_048
crossref_primary_10_1016_j_fertnstert_2011_03_001
crossref_primary_10_1016_j_jpag_2014_10_010
crossref_primary_10_1016_j_jadohealth_2020_07_008
crossref_primary_10_1016_j_rbmo_2019_06_014
crossref_primary_10_1159_000435883
crossref_primary_10_1016_j_fertnstert_2015_09_005
crossref_primary_10_2217_phe_09_69
crossref_primary_10_1016_j_fertnstert_2011_09_043
crossref_primary_10_1530_EJE_16_0374
crossref_primary_10_1016_j_fertnstert_2015_08_002
crossref_primary_10_1111_j_1464_5491_2010_02994_x
crossref_primary_10_1007_s13679_020_00388_9
crossref_primary_10_1016_j_jpeds_2015_09_082
crossref_primary_10_1080_01443615_2017_1345875
crossref_primary_10_1556_OH_2013_29527
crossref_primary_10_53394_akd_1037762
crossref_primary_10_3109_09513590_2012_708802
crossref_primary_10_1007_s13679_012_0030_y
crossref_primary_10_3892_etm_2017_4642
crossref_primary_10_1177_20420188211066699
crossref_primary_10_1111_j_1600_0412_2012_01417_x
crossref_primary_10_1016_j_jpag_2019_01_006
crossref_primary_10_3109_09513590_2010_508851
crossref_primary_10_1155_2013_972034
crossref_primary_10_1016_j_steroids_2013_04_011
crossref_primary_10_1530_EJE_10_0205
Cites_doi 10.1097/GRF.0b013e31802f3547
10.1016/S0021-9150(02)00236-8
10.1016/S0140-6736(07)60958-1
10.1016/j.jpeds.2007.09.010
10.1111/j.1399-5448.2007.00271.x
10.1210/jc.2005-1002
10.1210/jc.2003-032049
10.1093/humrep/15.4.785
10.1093/humrep/deg190
10.1016/S0015-0282(03)00265-6
10.1210/jc.2005-1666
10.1001/archpedi.157.8.821
10.1001/jama.295.13.1549
10.1016/S0015-0282(97)00486-X
10.1093/humrep/dei258
10.1016/j.atherosclerosis.2005.10.007
10.1016/j.fertnstert.2003.10.004
10.1210/jc.2005-1707
10.1210/jc.2007-2117
10.1542/peds.2006-1062
10.1177/009127002762491271
10.1016/S0895-4356(98)00010-9
10.1542/peds.2006-1699
10.1016/j.jpeds.2007.06.004
10.1210/jc.2007-1343
10.1016/S0140-6736(05)67402-8
10.1161/CIRCULATIONAHA.105.169404
10.1161/01.ATV.15.7.821
10.1016/j.atherosclerosis.2003.12.022
10.1097/GRF.0b013e31802f50fc
10.1210/jc.2005-1329
10.1161/HYPERTENSIONAHA.106.083972
10.1210/jc.2003-032046
10.1093/humrep/16.6.1255
10.1210/jc.2006-2725
10.1210/jc.2007-1834
10.1507/endocrj.51.467
ContentType Journal Article
Copyright Copyright © 2008 by The Endocrine Society 2008
2009 INIST-CNRS
Copyright © 2008 by The Endocrine Society
Copyright © 2008 by The Endocrine Society 2008
Copyright_xml – notice: Copyright © 2008 by The Endocrine Society 2008
– notice: 2009 INIST-CNRS
– notice: Copyright © 2008 by The Endocrine Society
– notice: Copyright © 2008 by The Endocrine Society 2008
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7X8
5PM
DOI 10.1210/jc.2008-1198
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
AIDS and Cancer Research Abstracts

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 4786
ExternalDocumentID PMC2626442
18812482
20971840
10_1210_jc_2008_1198
10.1210/jc.2008-1198
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: K23 HL086946
– fundername: NICHD NIH HHS
  grantid: K23 HD043881
– fundername: NCRR NIH HHS
  grantid: UL1 RR024160
– fundername: NHLBI NIH HHS
  grantid: K23 HL086946-01A1
– fundername: NICHD NIH HHS
  grantid: K23 HD043881-01A1
– fundername: NICHD NIH HHS
  grantid: R03 HD041989
– fundername: NCRR NIH HHS
  grantid: UL1 RR 024160
– fundername: NICHD NIH HHS
  grantid: 5 R03 HD41989-02
GroupedDBID ---
-~X
.55
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
4.4
48X
53G
5GY
5RS
5YH
8F7
AABZA
AACZT
AAIMJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
ABBLC
ABDFA
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVV
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
AELWJ
AEMDU
AENEX
AENZO
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFZL
AFGWE
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGQXC
AGUTN
AHMBA
AHMMS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BSWAC
BTRTY
C45
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EJD
EMOBN
ENERS
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
HZ~
H~9
KBUDW
KOP
KQ8
KSI
KSN
L7B
M5~
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
REU
ROX
ROZ
TEORI
TJX
TLC
TR2
TWZ
VVN
W8F
WOQ
X7M
YBU
YFH
YHG
YOC
YSK
ZY1
~02
~H1
AAYXX
ABXZS
ADNBA
AEMQT
AEOTA
AFYAG
AGORE
ALXQX
CITATION
NU-
.GJ
3O-
7X7
88E
8FI
8FJ
AAJQQ
AAKAS
AAPGJ
AAQQT
AAUQX
AAWDT
AAYJJ
ABDPE
ABUWG
ACFRR
ACVCV
ACZBC
ADMTO
ADZCM
AFFQV
AFKRA
AGMDO
AHGBF
AI.
AJBYB
AJDVS
APJGH
AQDSO
AQKUS
AVNTJ
BENPR
BPHCQ
BVXVI
CCPQU
EIHJH
FEDTE
FYUFA
HMCUK
HVGLF
IAO
IHR
INH
IQODW
ITC
J5H
M1P
MBLQV
OBFPC
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
TMA
UKHRP
VH1
WHG
X52
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
AEHZK
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-c434t-4fe677d09ee70d51bf99a6046e22b2343cefa32c15c528bb7e3efc211ab262df3
ISSN 0021-972X
IngestDate Thu Aug 21 18:09:12 EDT 2025
Mon Sep 08 12:45:53 EDT 2025
Fri Sep 19 20:58:35 EDT 2025
Mon Jul 21 05:22:24 EDT 2025
Mon Jul 21 09:17:05 EDT 2025
Tue Jul 01 04:01:29 EDT 2025
Thu Apr 24 22:50:31 EDT 2025
Fri Feb 07 10:35:41 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Endocrinopathy
Human
Obesity
Prevalence
Nutrition
Nutrition disorder
Cardiovascular disease
Female sterility
Metabolic diseases
Polycystic ovary
Metabolic syndrome
Epidemiology
Female genital diseases
Ovarian diseases
Cyst
Adolescent
Benign neoplasm
Endocrinology
Nutritional status
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c434t-4fe677d09ee70d51bf99a6046e22b2343cefa32c15c528bb7e3efc211ab262df3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Address all correspondence and requests for reprints to: Kathleen Hoeger, M.D., Associate Professor of Obstetrics and Gynecology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 668, Rochester, New York 14642. E-mail: Kathy_hoeger@urmc.rochester.edu.
PMID 18812482
PQID 3164406989
PQPubID 2046206
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2626442
proquest_miscellaneous_69871458
proquest_journals_3164406989
pubmed_primary_18812482
pascalfrancis_primary_20971840
crossref_primary_10_1210_jc_2008_1198
crossref_citationtrail_10_1210_jc_2008_1198
oup_primary_10_1210_jc_2008-1198
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-12-01
PublicationDateYYYYMMDD 2008-12-01
PublicationDate_xml – month: 12
  year: 2008
  text: 2008-12-01
  day: 01
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2008
Publisher Oxford University Press
Endocrine Society
The Endocrine Society
Publisher_xml – name: Oxford University Press
– name: Endocrine Society
– name: The Endocrine Society
References Ogden (2020071613345343400_R16) 2006; 295
Chen (2020071613345343400_R32) 2007; 49
Shroff (2020071613345343400_R29) 2007; 92
Talbott (2020071613345343400_R9) 1995; 15
Chang (2020071613345343400_R19) 2007; 50
Alberti (2020071613345343400_R14) 2005; 366
Zimmet (2020071613345343400_R13) 2007; 369
Azziz (2020071613345343400_R15) 2004; 89
Grundy (2020071613345343400_R11) 2005; 112
Ehrmann (2020071613345343400_R33) 2006; 91
Arslanian (2020071613345343400_R34) 2001; 86
Kirchengast (2020071613345343400_R22) 2001; 16
Yilmaz (2020071613345343400_R28) 2005; 20
Morrison (2020071613345343400_R39) 2008; 152
Coviello (2020071613345343400_R4) 2006; 91
Essah (2020071613345343400_R2) 2007; 50
Li (2020071613345343400_R18) 2006; 118
Cibula (2020071613345343400_R31) 2000; 15
Dunaif (2020071613345343400_R30) 1997; 18
Zimmet (2020071613345343400_R12) 2007; 8
Schachter (2020071613345343400_R27) 2003; 18
Tsikouris (2020071613345343400_R37) 2002; 42
Morrison (2020071613345343400_R38) 2007; 120
Ford (2020071613345343400_R6) 2004; 173
Onat (2020071613345343400_R7) 2002; 165
Cussons (2020071613345343400_R25) 2006; 185
Yildirim (2020071613345343400_R23) 2003; 79
Tarkun (2020071613345343400_R36) 2004; 51
Talbott (2020071613345343400_R8) 1998; 51
Cook (2020071613345343400_R10) 2003; 157
Leibel (2020071613345343400_R5) 2006; 91
Barber (2020071613345343400_R24) 2008; 93
Puder (2020071613345343400_R21) 2005; 90
Atiomo (2020071613345343400_R35) 1998; 69
Cook (2020071613345343400_R3) 2008; 152
Yildiz (2020071613345343400_R17) 2008; 93
Orio Jr (2020071613345343400_R26) 2004; 89
Carmina (2020071613345343400_R20) 2007; 92
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2020071613345343400_R1) 2004; 81
16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62
11387301 - Hum Reprod. 2001 Jun;16(6):1255-60
9619969 - J Clin Epidemiol. 1998 May;51(5):415-22
17304037 - Clin Obstet Gynecol. 2007 Mar;50(1):205-25
16249284 - J Clin Endocrinol Metab. 2006 Jan;91(1):48-53
17304035 - Clin Obstet Gynecol. 2007 Mar;50(1):178-87
15064107 - Atherosclerosis. 2004 Apr;173(2):309-14
17925334 - J Clin Endocrinol Metab. 2008 Jan;93(1):162-8
17405838 - J Clin Endocrinol Metab. 2007 Jul;92(7):2500-5
12912790 - Arch Pediatr Adolesc Med. 2003 Aug;157(8):821-7
17671060 - Pediatrics. 2007 Aug;120(2):340-5
18206689 - J Pediatr. 2008 Feb;152(2):201-6
10739820 - Hum Reprod. 2000 Apr;15(4):785-9
17848406 - J Clin Endocrinol Metab. 2007 Dec;92(12):4609-14
7600112 - Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):821-6
12660262 - Hum Reprod. 2003 Apr;18(4):721-7
16105965 - J Clin Endocrinol Metab. 2005 Nov;90(11):6014-21
17079540 - Pediatrics. 2006 Nov;118(5):e1390-8
17389259 - Hypertension. 2007 Jun;49(6):1442-7
16449341 - J Clin Endocrinol Metab. 2006 Apr;91(4):1275-83
16249280 - J Clin Endocrinol Metab. 2006 Feb;91(2):492-7
9496335 - Fertil Steril. 1998 Feb;69(2):236-41
12798883 - Fertil Steril. 2003 Jun;79(6):1358-64
14711538 - Fertil Steril. 2004 Jan;81(1):19-25
15181052 - J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9
16595758 - JAMA. 2006 Apr 5;295(13):1549-55
15516780 - Endocr J. 2004 Oct;51(5):467-72
16123091 - Hum Reprod. 2005 Dec;20(12):3333-40
18089693 - J Clin Endocrinol Metab. 2008 Mar;93(3):999-1004
12412817 - J Clin Pharmacol. 2002 Nov;42(11):1187-99
17850473 - Pediatr Diabetes. 2007 Oct;8(5):299-306
17586288 - Lancet. 2007 Jun 23;369(9579):2059-61
16313910 - Atherosclerosis. 2006 Apr;185(2):227-39
16157765 - Circulation. 2005 Oct 25;112(17):2735-52
18206683 - J Pediatr. 2008 Feb;152(2):165-70
12417279 - Atherosclerosis. 2002 Dec;165(2):285-92
11231980 - J Clin Endocrinol Metab. 2001 Jan;86(1):66-71
15292291 - J Clin Endocrinol Metab. 2004 Aug;89(8):3696-701
9408743 - Endocr Rev. 1997 Dec;18(6):774-800
References_xml – volume: 50
  start-page: 205
  year: 2007
  ident: 2020071613345343400_R2
  article-title: The metabolic syndrome in polycystic ovary syndrome.
  publication-title: Clin Obstet Gynecol
  doi: 10.1097/GRF.0b013e31802f3547
– volume: 165
  start-page: 285
  year: 2002
  ident: 2020071613345343400_R7
  article-title: Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation.
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(02)00236-8
– volume: 369
  start-page: 2059
  year: 2007
  ident: 2020071613345343400_R13
  article-title: The metabolic syndrome in children and adolescents.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60958-1
– volume: 152
  start-page: 201
  year: 2008
  ident: 2020071613345343400_R39
  article-title: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later.
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2007.09.010
– volume: 8
  start-page: 299
  year: 2007
  ident: 2020071613345343400_R12
  article-title: The metabolic syndrome in children and adolescents - an IDF consensus report.
  publication-title: Pediatr Diabetes
  doi: 10.1111/j.1399-5448.2007.00271.x
– volume: 90
  start-page: 6014
  year: 2005
  ident: 2020071613345343400_R21
  article-title: Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1002
– volume: 89
  start-page: 3696
  year: 2004
  ident: 2020071613345343400_R26
  article-title: The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-032049
– volume: 15
  start-page: 785
  year: 2000
  ident: 2020071613345343400_R31
  article-title: Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.
  publication-title: Hum Reprod
  doi: 10.1093/humrep/15.4.785
– volume: 18
  start-page: 721
  year: 2003
  ident: 2020071613345343400_R27
  article-title: Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine.
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deg190
– volume: 79
  start-page: 1358
  year: 2003
  ident: 2020071613345343400_R23
  article-title: Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome.
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(03)00265-6
– volume: 91
  start-page: 492
  year: 2006
  ident: 2020071613345343400_R4
  article-title: Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1666
– volume: 157
  start-page: 821
  year: 2003
  ident: 2020071613345343400_R10
  article-title: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994.
  publication-title: Arch Pediatr Adolesc Med
  doi: 10.1001/archpedi.157.8.821
– volume: 295
  start-page: 1549
  year: 2006
  ident: 2020071613345343400_R16
  article-title: Prevalence of overweight and obesity in the united states, 1999–2004.
  publication-title: JAMA
  doi: 10.1001/jama.295.13.1549
– volume: 69
  start-page: 236
  year: 1998
  ident: 2020071613345343400_R35
  article-title: The plasminogen activator system in women with polycystic ovary syndrome.
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(97)00486-X
– volume: 20
  start-page: 3333
  year: 2005
  ident: 2020071613345343400_R28
  article-title: The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dei258
– volume: 185
  start-page: 227
  year: 2006
  ident: 2020071613345343400_R25
  article-title: Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.10.007
– volume: 81
  start-page: 19
  year: 2004
  ident: 2020071613345343400_R1
  article-title: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2003.10.004
– volume: 91
  start-page: 1275
  year: 2006
  ident: 2020071613345343400_R5
  article-title: Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1707
– volume: 18
  start-page: 774
  year: 1997
  ident: 2020071613345343400_R30
  article-title: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
  publication-title: Endocr Rev
– volume: 93
  start-page: 999
  year: 2008
  ident: 2020071613345343400_R24
  article-title: Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2117
– volume: 118
  start-page: e1390
  year: 2006
  ident: 2020071613345343400_R18
  article-title: Recent trends in waist circumference and waist-height ratio among US children and adolescents
  publication-title: Pediatrics
  doi: 10.1542/peds.2006-1062
– volume: 42
  start-page: 1187
  year: 2002
  ident: 2020071613345343400_R37
  article-title: Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents.
  publication-title: J Clin Pharmacol
  doi: 10.1177/009127002762491271
– volume: 51
  start-page: 415
  year: 1998
  ident: 2020071613345343400_R8
  article-title: Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.
  publication-title: J Clin Epidemiol
  doi: 10.1016/S0895-4356(98)00010-9
– volume: 120
  start-page: 340
  year: 2007
  ident: 2020071613345343400_R38
  article-title: Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinic Follow-up Study.
  publication-title: Pediatrics
  doi: 10.1542/peds.2006-1699
– volume: 152
  start-page: 165
  year: 2008
  ident: 2020071613345343400_R3
  article-title: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999–2002.
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2007.06.004
– volume: 92
  start-page: 4609
  year: 2007
  ident: 2020071613345343400_R29
  article-title: Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-1343
– volume: 366
  start-page: 1059
  year: 2005
  ident: 2020071613345343400_R14
  article-title: The metabolic syndrome—a new worldwide definition.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67402-8
– volume: 112
  start-page: 2735
  year: 2005
  ident: 2020071613345343400_R11
  article-title: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.169404
– volume: 15
  start-page: 821
  year: 1995
  ident: 2020071613345343400_R9
  article-title: Coronary heart disease risk factors in women with polycystic ovary syndrome.
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.15.7.821
– volume: 173
  start-page: 309
  year: 2004
  ident: 2020071613345343400_R6
  article-title: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II mortality study.
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2003.12.022
– volume: 50
  start-page: 178
  year: 2007
  ident: 2020071613345343400_R19
  article-title: Polycystic ovary syndrome: early detection in the adolescent.
  publication-title: Clin Obstet Gynecol
  doi: 10.1097/GRF.0b013e31802f50fc
– volume: 91
  start-page: 48
  year: 2006
  ident: 2020071613345343400_R33
  article-title: Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1329
– volume: 86
  start-page: 66
  year: 2001
  ident: 2020071613345343400_R34
  article-title: Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease.
  publication-title: J Clin Endocrinol Metab
– volume: 49
  start-page: 1442
  year: 2007
  ident: 2020071613345343400_R32
  article-title: Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.106.083972
– volume: 89
  start-page: 2745
  year: 2004
  ident: 2020071613345343400_R15
  article-title: The prevalence and features of the polycystic ovary syndrome in an unselected population.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-032046
– volume: 16
  start-page: 1255
  year: 2001
  ident: 2020071613345343400_R22
  article-title: Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome.
  publication-title: Hum Reprod
  doi: 10.1093/humrep/16.6.1255
– volume: 92
  start-page: 2500
  year: 2007
  ident: 2020071613345343400_R20
  article-title: Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-2725
– volume: 93
  start-page: 162
  year: 2008
  ident: 2020071613345343400_R17
  article-title: Impact of obesity on the risk for polycystic ovary syndrome.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-1834
– volume: 51
  start-page: 467
  year: 2004
  ident: 2020071613345343400_R36
  article-title: The plasminogen activator system in young and lean women with polycystic ovary syndrome.
  publication-title: Endocr J
  doi: 10.1507/endocrj.51.467
– reference: 16249280 - J Clin Endocrinol Metab. 2006 Feb;91(2):492-7
– reference: 17304035 - Clin Obstet Gynecol. 2007 Mar;50(1):178-87
– reference: 14711538 - Fertil Steril. 2004 Jan;81(1):19-25
– reference: 17586288 - Lancet. 2007 Jun 23;369(9579):2059-61
– reference: 12798883 - Fertil Steril. 2003 Jun;79(6):1358-64
– reference: 15292291 - J Clin Endocrinol Metab. 2004 Aug;89(8):3696-701
– reference: 16249284 - J Clin Endocrinol Metab. 2006 Jan;91(1):48-53
– reference: 12417279 - Atherosclerosis. 2002 Dec;165(2):285-92
– reference: 16105965 - J Clin Endocrinol Metab. 2005 Nov;90(11):6014-21
– reference: 17079540 - Pediatrics. 2006 Nov;118(5):e1390-8
– reference: 17405838 - J Clin Endocrinol Metab. 2007 Jul;92(7):2500-5
– reference: 17389259 - Hypertension. 2007 Jun;49(6):1442-7
– reference: 18206683 - J Pediatr. 2008 Feb;152(2):165-70
– reference: 15516780 - Endocr J. 2004 Oct;51(5):467-72
– reference: 16313910 - Atherosclerosis. 2006 Apr;185(2):227-39
– reference: 18206689 - J Pediatr. 2008 Feb;152(2):201-6
– reference: 11231980 - J Clin Endocrinol Metab. 2001 Jan;86(1):66-71
– reference: 12660262 - Hum Reprod. 2003 Apr;18(4):721-7
– reference: 16595758 - JAMA. 2006 Apr 5;295(13):1549-55
– reference: 15181052 - J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9
– reference: 16449341 - J Clin Endocrinol Metab. 2006 Apr;91(4):1275-83
– reference: 9408743 - Endocr Rev. 1997 Dec;18(6):774-800
– reference: 17304037 - Clin Obstet Gynecol. 2007 Mar;50(1):205-25
– reference: 16123091 - Hum Reprod. 2005 Dec;20(12):3333-40
– reference: 17925334 - J Clin Endocrinol Metab. 2008 Jan;93(1):162-8
– reference: 17850473 - Pediatr Diabetes. 2007 Oct;8(5):299-306
– reference: 16157765 - Circulation. 2005 Oct 25;112(17):2735-52
– reference: 9619969 - J Clin Epidemiol. 1998 May;51(5):415-22
– reference: 17848406 - J Clin Endocrinol Metab. 2007 Dec;92(12):4609-14
– reference: 9496335 - Fertil Steril. 1998 Feb;69(2):236-41
– reference: 18089693 - J Clin Endocrinol Metab. 2008 Mar;93(3):999-1004
– reference: 7600112 - Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):821-6
– reference: 12412817 - J Clin Pharmacol. 2002 Nov;42(11):1187-99
– reference: 17671060 - Pediatrics. 2007 Aug;120(2):340-5
– reference: 11387301 - Hum Reprod. 2001 Jun;16(6):1255-60
– reference: 10739820 - Hum Reprod. 2000 Apr;15(4):785-9
– reference: 12912790 - Arch Pediatr Adolesc Med. 2003 Aug;157(8):821-7
– reference: 15064107 - Atherosclerosis. 2004 Apr;173(2):309-14
– reference: 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62
SSID ssj0014453
Score 2.2943532
Snippet Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear...
Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether...
Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4780
SubjectTerms Adipose tissue
Adipose Tissue - pathology
Adiposity - physiology
Adolescent
Adolescents
Anthropometry
Biological and medical sciences
Biomarkers
Blood Glucose - metabolism
Blood pressure
Blood Pressure - physiology
Body Mass Index
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - complications
Cardiovascular Diseases - epidemiology
Child
Cholesterol, HDL - blood
Computed tomography
Cross-Sectional Studies
Endocrinopathies
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Glucose
Glucose tolerance
Humans
Lipids
Medical sciences
Metabolic syndrome
Metabolic Syndrome - complications
Metabolic Syndrome - epidemiology
Obesity
Obesity - complications
Obesity - epidemiology
Original
Ovaries
Pediatrics
Plasminogen Activator Inhibitor 1 - blood
Plasminogen activator inhibitors
Polycystic ovary syndrome
Polycystic Ovary Syndrome - complications
Polycystic Ovary Syndrome - epidemiology
Risk Factors
Teenagers
Testosterone
Tomography, X-Ray Computed
Triglycerides - blood
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vertebrates: endocrinology
Waist Circumference
Title Prevalence of Metabolic Syndrome and Related Characteristics in Obese Adolescents with and without Polycystic Ovary Syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/18812482
https://www.proquest.com/docview/3164406989
https://www.proquest.com/docview/69871458
https://pubmed.ncbi.nlm.nih.gov/PMC2626442
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELaWIiEkhLhJKcUP8LQK2jhOnH1EFaiAOKS2Ut8i27HFwjapuruVWvEX-U_MxM612hXHS5Rj4hzzxZ5xZr4h5GVkoMtjKg2NkeCgaGZDBYZ9mCk2tdyAxaHrKN_P6eEJ_3CanI5Gv3pRS6uleq2vN-aV_I9WYR_oFbNk_0GzbaOwA9ZBv7AEDcPyr3SM_EuyzhqqI1nMEjSKpNVHnobAZx_OJZqVB2vUzLNyjFUBjK-ypIepbriCIctfq_mVvsIzxl8uMcLuaAPFAWKtR0HRZluasqigVyo7nqczf4-et9CVdlzMHMqQ_bP7SfUDPARXpwpnrVuD-6K67kfldPFDOPnk-BAKeTaYzMjWAkO2JEn2O3CMKBF1BXYYvlyfPeVJKCIX5tt06q7sYgNe1uuiuXClo_xwD5vpxqEEfGEcSmqaS7jPyBXLXiPn3ix4g9xkAkw5tNHff2x_anHuSVH9M_g8DEyi6p89sJBc1uWdc7kAtVlXa2WTM7Qe09szko7vkbveu6FvHFTvk5EpH5Bbn3z8xkPys0MsrSxtEUsbVFEACfWIpWuIpbOS1oilPcRSBGp9lkcs7RBLa8S2bT8iJ-_eHh8chr7-R6h5zJchtyYVophMjRGTIomUnU5lOuGpYUyxmMfaWBkzHSU6YZlSwsTGahZFUrGUFTZ-THbKqjRPCRUiNYWKMystToCkisdKFLwAC1FAuzIg4-ad59qT42ONlnmOTjJoKP-uXcVW1FBAXrXS544UZoscBfVtEwmdyP5At60wQ3K3jE8CstcoO_df8iKPI3BjJlj7NSAv2sMwMODfPlmaarXI4aiIeAJXeOKQ0d1HhlZ9xgIiBphpBZByfniknH2rqefhvcKV2e6fH-wZud194HtkZ3mxMs_Bfl-q_fqr-A3jzPZf
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Metabolic+Syndrome+and+Related+Characteristics+in+Obese+Adolescents+with+and+without+Polycystic+Ovary+Syndrome&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Rossi%2C+Brooke&rft.au=Sukalich%2C+Sara&rft.au=Droz%2C+Jennifer&rft.au=Griffin%2C+Adam&rft.date=2008-12-01&rft.pub=Oxford+University+Press&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=93&rft.issue=12&rft.spage=4780&rft.epage=4786&rft_id=info:doi/10.1210%2Fjc.2008-1198&rft.externalDocID=10.1210%2Fjc.2008-1198
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon